Tech Company Financing Transactions
SelectX Pharmaceuticals Funding Round
On 12/31/2008, SelectX Pharmaceuticals raised $21.5 million in funding from TVM Capital and private investors.
Transaction Overview
Company Name
Announced On
12/31/2008
Transaction Type
Venture Equity
Amount
$21,500,000
Round
Undisclosed
Investors
TVM Capital (Helmut Schühsler)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
607 Boylston St. LL
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Website
Email Address
Overview
SelectX Pharmaceuticals, Inc. is rapidly establishing itself as a leader in the innovation and application of Genetic Chemistry for small molecule drug discovery. The Company focuses its discovery and development efforts on antimicrobial and other therapeutics that address unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Chaparian
VP - Engineering
George Drusano
Browse more venture capital transactions:
Prev: 12/31/2008: Philadelphia Renewable Energy venture capital transaction
Next: 12/31/2008: Phoenix Energy Technologies venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs